mixing tirzepatide with semaglutide Maintenance therapy on or Switching Semaglutide to Tirzepatide |

The most common gastrointestinal side effects include: Nausea very common (may affect more than 1 in 10 people), most pronounced during the first 4-5 weeks Diarrhoea common (may affect up to 1 in 10 people) Vomiting common (may affect up to 1 in 10 people) Abdominal pain common (may affect up to 1 in 10 people) Constipation common (may affect up to 1 in 10 people) Dyspepsia and flatulence common (may affect up to 1 in 10 people) Whilst belching may occur, 'sulphur burps' are not specifically enumerated as a distinct adverse effect in the SmPC

Inflammatory markers in non-obese women with polycystic ovary syndrome are not elevated and show no correlation with vitamin d metabolites

1 Die Entdeckung der Sttigungshormone hat zu einer neuen Generation von Wirkstoffen gefhrt, die mehrere hormonelle Signalwege gleichzeitig aktivieren

Sulkowski, M